Cargando…
New formulation of a recombinant anthrax vaccine stabilised with structurally modified plant viruses
Anthrax is a disease caused by Bacillus anthracis. The most promising approach to the development of anthrax vaccine is use of the anthrax protective antigen (PA). At the same time, recombinant PA is a very unstable protein. Previously, the authors have designed a stable modified recombinant anthrax...
Autores principales: | Granovskiy, Dmitriy L., Ryabchevskaya, Ekaterina M., Evtushenko, Ekaterina A., Kondakova, Olga A., Arkhipenko, Marina V., Kravchenko, Tatiana B., Bakhteeva, Irina V., Timofeev, Vitalii S., Nikitin, Nikolai A., Karpova, Olga V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501872/ https://www.ncbi.nlm.nih.gov/pubmed/36160184 http://dx.doi.org/10.3389/fmicb.2022.1003969 |
Ejemplares similares
-
Designing Stable Bacillus anthracis Antigens with a View to Recombinant Anthrax Vaccine Development
por: Ryabchevskaya, Ekaterina M., et al.
Publicado: (2022) -
Novel antigen panel for modern broad-spectrum recombinant rotavirus A vaccine
por: Kondakova, Olga A., et al.
Publicado: (2021) -
Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy
por: Nikitin, Nikolai, et al.
Publicado: (2023) -
Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant
por: Kovalenko, Angelina O., et al.
Publicado: (2022) -
Some Peculiarities of Anthrax Epidemiology in Herbivorous and Carnivorous Animals
por: Bakhteeva, Irina, et al.
Publicado: (2022)